Physician profile
Rawan Rumman
NPI 1649955048
$3,862.59
in general payments reported to CMS, 2019-2025
8 companies · $3,387 in 2025
The $3,387 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $92.76 · 2024: $382 · 2025: $3,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,342 · Travel and Lodging: $1,206 · Education: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,342.14 |
| Travel and Lodging | $1,206.18 |
| Education | $314.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,980.00 | 2025 | Optis, Dragonfly Opstar, Coroflow |
| Shockwave Medical, INC | $948.29 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $296.00 | 2025 | General - Vascular Access, General - Therapies, Rotapro |
| Medtronic, INC. | $221.24 | 2025 | Resolute Onyx |
| Terumo Medical Corporation | $163.74 | 2023-2025 | Angio-Seal, Tr Band, Glidesheath Slender |
| Abiomed | $155.55 | 2025 | |
| Atricure, INC. | $75.50 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Edwards Lifesciences Corporation | $22.27 | 2024 | Pascal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rawan Rumman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.